When speaking with your GP, it may be helpful to discuss: Your current BMI and any weight-related health conditions Whether you meet the criteria for existing licensed weight management medications Your reproductive health status, contraception, and any plans for pregnancy Any personal or family history of thyroid disease, pancreatitis, or gallbladder problems Your interest in clinical trials, should you wish to explore participation in retatrutide research Staying informed about emerging treatments is entirely reasonable, but it is important to do so through reliable sources such as the NHS website (nhs.uk), NICE (nice.org.uk), and the MHRA (gov.uk/mhra)
Neuropeptides 94 , 102250 (2022)
While the costs of the two medications are similar, there is research that highlights semaglutide GLP-1 as the more cost-effective option when it comes to weight loss treatment
Potential risks include: Overdosing, which can result in severe nausea, vomiting, or hypoglycemia
A strong PBM partner should help you evaluate both the clinical value and financial impact so you can determine the right approach for your plan
